179
0
0
Like?
Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Antibiotics and Affect: Avenues for Addiction Management
Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...
A randomized and controlled trial to examine the impact of lingual frenotomy on bottle feeding mechanics
Some babies are born with tongue-tie where an unusually short or tight band of tissue tethers the bottom...
A scientific approach to placenta remedies: What hormones are found in placenta tissue?
The human placenta contains a mixture of substances which may be useful for individual postpartum treatment...